88 related articles for article (PubMed ID: 21824053)
1. Gastric mucosa-associated lymphoid tissue lymphoma: how to attack the T… for two?
Neubauer A; Huynh M
Leuk Lymphoma; 2011 Dec; 52(12):2203-4. PubMed ID: 21824053
[No Abstract] [Full Text] [Related]
2. Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment.
de Boer JP; Raderer M; van Tinteren H; Aleman BM; Boot H; de Jong D
Leuk Lymphoma; 2011 Dec; 52(12):2262-9. PubMed ID: 21848361
[TBL] [Abstract][Full Text] [Related]
3. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
Zinzani PL; Stefoni V; Musuraca G; Tani M; Alinari L; Gabriele A; Marchi E; Pileri S; Baccarani M
Cancer; 2004 May; 100(10):2190-4. PubMed ID: 15139063
[TBL] [Abstract][Full Text] [Related]
4. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
6. Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab.
Salar A; Bellosillo B; Serrano S; Besses C
J Clin Oncol; 2005 Oct; 23(29):7361-2; author reply 7362-3. PubMed ID: 16210674
[No Abstract] [Full Text] [Related]
7. Contemplating the Diagnostic Certainty of Primary Iris Mucosa-Associated Lymphoid Tissue Lymphoma.
Margo CE
JAMA Ophthalmol; 2015 Aug; 133(8):969-70. PubMed ID: 25950116
[No Abstract] [Full Text] [Related]
8. Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?
Peinert S; Carney D; Prince HM; Januszewicz EH; Seymour JF
Br J Haematol; 2009 Sep; 146(6):685-6. PubMed ID: 19638019
[No Abstract] [Full Text] [Related]
9. Contemplating the Diagnostic Certainty of Primary Iris Mucosa-Associated Lymphoid Tissue Lymphoma—Reply.
Demirci H; Elner VM
JAMA Ophthalmol; 2015 Aug; 133(8):970. PubMed ID: 25950277
[No Abstract] [Full Text] [Related]
10. Possible clinical effects of macrolides on the treatment of primary pulmonary mucosa-associated lymphoid tissue lymphoma.
Yatera K; Ishimatsu Y; Sakamoto N; Mukae H
Int J Hematol; 2016 Feb; 103(2):251-2. PubMed ID: 26590918
[No Abstract] [Full Text] [Related]
11. Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
Jäger G; Neumeister P; Quehenberger F; Wöhrer S; Linkesch W; Raderer M
Ann Oncol; 2006 Nov; 17(11):1722-3. PubMed ID: 16766585
[No Abstract] [Full Text] [Related]
12. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of mucosa-associated lymphoid tissue lymphoma with plasma cell features and adenocarcinoma cells in pleural fluid.
Ohno H
J Clin Exp Hematop; 2010; 50(1):75-7. PubMed ID: 20505280
[No Abstract] [Full Text] [Related]
14. Treatment of conjunctival mucosa-associated lymphoid tissue lymphoma with intralesional injection of interferon alfa-2b.
Lachapelle KR; Rathee R; Kratky V; Dexter DF
Arch Ophthalmol; 2000 Feb; 118(2):284-5. PubMed ID: 10676800
[No Abstract] [Full Text] [Related]
15. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
[TBL] [Abstract][Full Text] [Related]
16. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger G; Neumeister P; Brezinschek R; Hinterleitner T; Fiebiger W; Penz M; Neumann HJ; Mlineritsch B; DeSantis M; Quehenberger F; Chott A; Beham-Schmid C; Höfler G; Linkesch W; Raderer M
J Clin Oncol; 2002 Sep; 20(18):3872-7. PubMed ID: 12228207
[TBL] [Abstract][Full Text] [Related]
17. Successful rituximab monotherapy for API2-MALT1 fusion positive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis.
Yamada M; Kawahara H; Shiroeda H; Tsuchishima M; Masaki Y; Sato K; Takase S
Scand J Gastroenterol; 2008; 43(6):761-4. PubMed ID: 18569996
[No Abstract] [Full Text] [Related]
18. Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents.
Donaldson SL; Owen RG; McGonagle DG
J Rheumatol; 2014 Dec; 41(12):2496-7. PubMed ID: 25452189
[No Abstract] [Full Text] [Related]
19. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
20. Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx.
Arndt S; Veelken H; Schmitt-Gräff A; Aschendorff A; Maier W; Richter B
Ann Otol Rhinol Laryngol; 2007 Apr; 116(4):257-61. PubMed ID: 17491523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
